Claire Leurent

Immunotherapy with ponezumab for probable cerebral amyloid angiopathy

Claire Leurent, James Goodman, Yao Zhang et al. · Annals of Clinical and Translational Neurology · 2019 · 74 citations · Full text

Pharmacokinetic and Pharmacodynamic Effects of a γ‐Secretase Modulator, <scp>PF</scp>‐06648671, on <scp>CSF</scp> Amyloid‐β Peptides in Randomized Phase I Studies

Jae Eun Ahn, Charles Carrieri, Fernando Dela Cruz et al. · Clinical Pharmacology & Therapeutics · 2019 · 32 citations · Full text

γ‐Secretase Modulator, Neurochemical Biomarkers, Peptide Science +19

Desvenlafaxine for the Prevention of Relapse in Major Depressive Disorder

Karl Rickels, Stuart Montgomery, Karen A. Tourian et al. · Journal of Clinical Psychopharmacology · 2010 · 31 citations

Systems pharmacology modeling in neuroscience: Prediction and outcome of PF-04995274, a 5-HT4 partial agonist, in a clinical scopolamine impairment trial

Timothy Nicholas, Sridhar Duvvuri, Claire Leurent et al. · Advances in Alzheimer s Disease · 2013 · 29 citations · Full text

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PF-06751979, a Potent and Selective Oral BACE1 Inhibitor: Results from Phase I Studies in Healthy Adults and Healthy Older Subjects

Ruolun Qiu, Jae Eun Ahn, Robert Alexander et al. · Journal of Alzheimer s Disease · 2019 · 24 citations · Full text